General Information of the Cell Line
Cell Line ID
CL000122
Cell Line Name
GIST-T1
Synonyms
GIST-T-1
GISTT1
T1
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_4976
Tissue Information
Pleural effusion
Disease
Gastrointestinal stromal tumor (NCIt: C3868)
Gastrointestinal stromal tumor (ORDO: Orphanet_44890)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00888, Mast/stem cell growth factor receptor Kit
Compound ID Compound Name Compound Formula
CP0421231
N-[[1-[4-[[3-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamoylamino]-2-(trifluoromethyl)phenyl]piperidin-4-yl]methyl]propanamide
   Show/Hide
C34H36F3N5O5
 2
1
EC50 < 100 nM
   TI
   LI
   LO
   TS
2
GI50 = 4 nM
   TI
   LI
   LO
   TS
CP0035428
3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide
   Show/Hide
C29H27F3N6O
 2
1
GI50 = 2.2 nM
   TI
   LI
   LO
   TS
2
GI50 = 9.6 nM
   TI
   LI
   LO
   TS
CP0002211
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
   Show/Hide
C22H27FN4O2
 1
1
GI50 = 5 nM
   TI
   LI
   LO
   TS
CP0002778
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
C29H31N7O
 3
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
2
GI50 = 27 nM
   TI
   LI
   LO
   TS
3
GI50 >= 30000 nM
   TI
   LI
   LO
   TS
CP0096180
1-[5-tert-butyl-2-(3-nitrophenyl)pyrazol-3-yl]-3-[4-(quinazolin-4-ylamino)phenyl]urea
   Show/Hide
C28H26N8O3
 2
1
GI50 = 10.8 nM
   TI
   LI
   LO
   TS
2
GI50 = 23.6 nM
   TI
   LI
   LO
   TS
CP0240254
1-[4-[(6-aminoquinazolin-4-yl)amino]phenyl]-3-[4-chloro-3-(trifluoromethyl)phenyl]urea
   Show/Hide
C22H16ClF3N6O
 2
1
GI50 = 11.8 nM
   TI
   LI
   LO
   TS
2
GI50 = 121 nM
   TI
   LI
   LO
   TS
CP0059308
1-[2-(3-aminophenyl)-5-tert-butylpyrazol-3-yl]-3-[4-(quinazolin-4-ylamino)phenyl]urea
   Show/Hide
C28H28N8O
 2
1
GI50 = 17.2 nM
   TI
   LI
   LO
   TS
2
GI50 = 27.7 nM
   TI
   LI
   LO
   TS
CP0180491
1-[2-(3-aminophenyl)-5-tert-butylpyrazol-3-yl]-3-[4-[(6-aminoquinazolin-4-yl)amino]phenyl]urea
   Show/Hide
C28H29N9O
 2
1
GI50 = 105 nM
   TI
   LI
   LO
   TS
2
GI50 = 110 nM
   TI
   LI
   LO
   TS
CP0490017
1,4-Hybrid, 5
   Show/Hide
C31H33N9O2
 2
1
GI50 = 208 nM
   TI
   LI
   LO
   TS
2
GI50 = 324 nM
   TI
   LI
   LO
   TS
CP0368036
N-[4-[4-[[2-(3-aminophenyl)-5-tert-butylpyrazol-3-yl]carbamoylamino]anilino]quinazolin-6-yl]-3-(4-methylpiperazin-1-yl)propanamide
   Show/Hide
C36H43N11O2
 2
1
GI50 = 385 nM
   TI
   LI
   LO
   TS
2
GI50 = 402 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0002211
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
   Show/Hide
C22H27FN4O2  2
1
GI50 = 38 nM
   TI
   LI
   LO
   TS
2
GI50 = 5880 nM
   TI
   LI
   LO
   TS
CP0002778
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
C29H31N7O  1
1
GI50 = 40 nM
   TI
   LI
   LO
   TS
CP0035428
3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide
   Show/Hide
C29H27F3N6O  1
1
GI50 = 106 nM
   TI
   LI
   LO
   TS
CP0043225
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
   Show/Hide
C21H15ClF4N4O3  2
1
GI50 = 130 nM
   TI
   LI
   LO
   TS
2
GI50 = 1350 nM
   TI
   LI
   LO
   TS
CP0135795
1-(5-ethyl-1,2-oxazol-3-yl)-3-[4-[2-[[6-(4-ethylpiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazol-5-yl]phenyl]urea
   Show/Hide
C25H29N9O2S  1
1
GI50 = 2.2 nM
   TI
   LI
   LO
   TS
CP0161700
4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-(2-pyridin-2-ylethynyl)benzamide
   Show/Hide
C28H27F3N4O  2
1
GI50 = 55 nM
   TI
   LI
   LO
   TS
2
GI50 = 97 nM
   TI
   LI
   LO
   TS
CP0184068
3-[2-(1-aminoisoquinolin-4-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C32H30F3N5O  2
1
GI50 = 301 nM
   TI
   LI
   LO
   TS
2
GI50 = 645 nM
   TI
   LI
   LO
   TS
CP0184069
3-[2-(6-amino-5-methylpyridin-3-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C29H30F3N5O  1
1
GI50 = 474 nM
   TI
   LI
   LO
   TS
CP0191187
4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-([1,2,4]triazolo[4,3-a]pyridin-7-yl)ethynyl]benzamide
   Show/Hide
C29H27F3N6O  1
1
GI50 = 282 nM
   TI
   LI
   LO
   TS
CP0270974
4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(pyridin-3-ylethynyl)benzamide
   Show/Hide
C28H27F3N4O  2
1
GI50 = 76 nM
   TI
   LI
   LO
   TS
2
GI50 = 332 nM
   TI
   LI
   LO
   TS
CP0351448
3-(2-imidazo[1,2-a]pyridin-7-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C30H28F3N5O  2
1
GI50 = 59 nM
   TI
   LI
   LO
   TS
2
GI50 = 184 nM
   TI
   LI
   LO
   TS
CP0351449
2-ethyl-3-iodo-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C22H25F3IN3O  1
1
GI50 = 11006 nM
   TI
   LI
   LO
   TS
CP0382323
1-[4-[2-[[6-(3-aminopyrrolidin-1-yl)-2-methylpyrimidin-4-yl]amino]-1,3-thiazol-5-yl]phenyl]-3-(5-ethyl-1,2-oxazol-3-yl)urea
   Show/Hide
C24H27N9O2S  1
1
GI50 = 6.4 nM
   TI
   LI
   LO
   TS
CP0436766
3-[2-(2-aminopyrimidin-5-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C27H27F3N6O  2
1
GI50 = 23 nM
   TI
   LI
   LO
   TS
2
GI50 = 141 nM
   TI
   LI
   LO
   TS
CP0436767
3-[2-(2-aminopyrimidin-5-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]benzamide
   Show/Hide
C26H28N6O  2
1
GI50 = 33 nM
   TI
   LI
   LO
   TS
2
GI50 = 1269 nM
   TI
   LI
   LO
   TS
CP0437868
4-[(4-methylpiperazin-1-yl)methyl]-N-(5-pyridin-3-yl-1,3-thiazol-2-yl)benzamide;hydrochloride
   Show/Hide
C21H24ClN5OS  1
1
GI50 = 647 nM
   TI
   LI
   LO
   TS
CP0448634
3-[2-(3-methoxypyridin-2-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C29H29F3N4O2  2
1
GI50 = 82 nM
   TI
   LI
   LO
   TS
2
GI50 = 991 nM
   TI
   LI
   LO
   TS
CP0461776
3-[2-(6-aminopyridazin-3-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C27H27F3N6O  1
1
GI50 = 580 nM
   TI
   LI
   LO
   TS
CP0470772
N-[6-(4-ethylpiperazin-1-yl)-2-methylpyrimidin-4-yl]-5-pyridin-2-yl-1,3-thiazol-2-amine;hydrochloride
   Show/Hide
C19H24ClN7S  1
1
GI50 = 42 nM
   TI
   LI
   LO
   TS
CP0471979
1-(5-ethyl-1,2-oxazol-3-yl)-3-[4-[2-[[4-(4-ethylpiperazin-1-yl)-6-methyl-1,3,5-triazin-2-yl]amino]-1,3-thiazol-5-yl]phenyl]urea
   Show/Hide
C25H30N10O2S  1
1
GI50 = 13 nM
   TI
   LI
   LO
   TS
CP0474207
1-(5-ethyl-1,2-oxazol-3-yl)-3-[5-[2-[[6-(4-ethylpiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazol-5-yl]pyridin-2-yl]urea
   Show/Hide
C24H28N10O2S  1
1
GI50 = 1 nM
   TI
   LI
   LO
   TS
CP0478857
N-[6-(4-ethylpiperazin-1-yl)-2-methylpyrimidin-4-yl]-5-phenyl-1,3-thiazol-2-amine;hydrochloride
   Show/Hide
C20H25ClN6S  1
1
GI50 = 8 nM
   TI
   LI
   LO
   TS
CP0479774
1-(5-ethyl-1,2-oxazol-3-yl)-3-[3-[2-[[6-(4-ethylpiperazin-1-yl)-2-methylpyrimidin-4-yl]amino]-1,3-thiazol-5-yl]propyl]urea
   Show/Hide
C23H33N9O2S  1
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
CP0489728
N-[6-[4-(dimethylamino)piperidin-1-yl]-2-methylpyrimidin-4-yl]-5-pyridin-4-yl-1,3-thiazol-2-amine;hydrochloride
   Show/Hide
C20H26ClN7S  1
1
GI50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0490827
N-[6-(4-ethylpiperazin-1-yl)-2-methylpyrimidin-4-yl]-4-pyridin-3-yl-1,3-thiazol-2-amine;hydrochloride
   Show/Hide
C19H24ClN7S  1
1
GI50 > 1000 nM
   TI
   LI
   LO
   TS
CP0492040
2-[4-[2-methyl-6-[(5-pyridin-4-yl-1,3-thiazol-2-yl)amino]pyrimidin-4-yl]piperazin-1-yl]ethanol;hydrochloride
   Show/Hide
C19H24ClN7OS  1
1
GI50 = 2.8 nM
   TI
   LI
   LO
   TS
CP0531605
4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-3-(2-pyridin-3-ylethynyl)benzamide
   Show/Hide
C27H28N4O  1
1
GI50 = 9610 nM
   TI
   LI
   LO
   TS
CP0538609
N-[6-(4-ethylpiperazin-1-yl)pyrimidin-4-yl]-5-pyridin-4-yl-1,3-thiazol-2-amine;hydrochloride
   Show/Hide
C18H22ClN7S  1
1
GI50 = 15 nM
   TI
   LI
   LO
   TS
CP0538822
3-[2-(2-aminopyrimidin-5-yl)ethynyl]-N-[3-fluoro-4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-methylbenzamide
   Show/Hide
C26H27FN6O  3
1
GI50 = 31 nM
   TI
   LI
   LO
   TS
2
GI50 = 904 nM
   TI
   LI
   LO
   TS
3
GI50 = 1362 nM
   TI
   LI
   LO
   TS
CP0538824
4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(5-phenylmethoxypyridin-2-yl)ethynyl]benzamide
   Show/Hide
C35H33F3N4O2  1
1
GI50 = 121 nM
   TI
   LI
   LO
   TS
CP0539523
[4-[2-[[6-(4-ethylpiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazol-5-yl]phenyl]urea
   Show/Hide
C20H24N8OS  1
1
GI50 = 86 nM
   TI
   LI
   LO
   TS
CP0543112
1-(5-ethyl-1,2-oxazol-3-yl)-3-[4-[2-[[6-(4-ethylpiperazin-1-yl)pyrimidin-4-yl]amino]-4-methyl-1,3-thiazol-5-yl]phenyl]urea
   Show/Hide
C26H31N9O2S  1
1
GI50 = 3.3 nM
   TI
   LI
   LO
   TS
CP0552987
N-(5-ethyl-1,2-oxazol-3-yl)-4-[2-[[6-(4-ethylpiperazin-1-yl)-2-methylpyrimidin-4-yl]amino]-1,3-thiazol-5-yl]-3,6-dihydro-2H-pyridine-1-carboxamide
   Show/Hide
C25H33N9O2S  1
1
GI50 = 4.9 nM
   TI
   LI
   LO
   TS
CP0562854
1-(5-ethyl-1,2-oxazol-3-yl)-3-[4-[2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]pyrimidin-4-yl]amino]-1,3-thiazol-5-yl]phenyl]urea
   Show/Hide
C25H29N9O3S  1
1
GI50 = 3.3 nM
   TI
   LI
   LO
   TS
CP0574423
N-[4-[2-[[6-(4-ethylpiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazol-5-yl]phenyl]acetamide
   Show/Hide
C21H25N7OS  1
1
GI50 = 25 nM
   TI
   LI
   LO
   TS
CP0574424
1-(5-ethyl-1,2-oxazol-3-yl)-3-[4-[2-[[6-(4-ethylpiperazin-1-yl)-2-methylpyrimidin-4-yl]amino]-1,3-thiazol-4-yl]phenyl]urea
   Show/Hide
C26H31N9O2S  1
1
GI50 > 1000 nM
   TI
   LI
   LO
   TS
CP0641297
N-(5-ethyl-3-isoxazolyl)-N'-[4-(2-[6-(4-ethylpiperazino)-2-methyl-4-pyrimidinyl]amino-1,3-thiazol-5-yl)phenyl]urea
   Show/Hide
C26H31N9O2S  1
1
GI50 = 3.2 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/A02 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
SUP-T1 Homo sapiens (Human) Childhood T lymphoblastic lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
T-47D Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF/MX Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-6 Homo sapiens (Human) Lung adenocarcinoma
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3255 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
NCI-H460 Homo sapiens (Human) Lung large cell carcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma